94 related articles for article (PubMed ID: 9041968)
1. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions.
Chin NK; Lim TK
Chest; 1997 Feb; 111(2):275-9. PubMed ID: 9041968
[TBL] [Abstract][Full Text] [Related]
2. Benefit of intrapleural fibrinolytic therapy in the treatment of complicated parapneumonic effusion and empyema.
Merhabene T; Zayet S; Jamoussi A; Ayed S; Mansouri S; Khelil JB; Besbes M
Pan Afr Med J; 2024; 47():54. PubMed ID: 38646137
[TBL] [Abstract][Full Text] [Related]
3. Steroid therapy and outcome of parapneumonic pleural effusions (STOPPE): Study protocol for a multicenter, double-blinded, placebo-controlled randomized clinical trial.
Fitzgerald DB; Waterer GW; Read CA; Fysh ET; Shrestha R; Stanley C; Muruganandan S; Lan NSH; Popowicz ND; Peddle-McIntyre CJ; Rahman NM; Gan SK; Murray K; Lee YCG
Medicine (Baltimore); 2019 Oct; 98(43):e17397. PubMed ID: 31651842
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Pleural Space Infections in Patients With Indwelling Pleural Catheters for Active Malignancies.
Chang CH; Ost DE; Jimenez CA; Saltijeral SN; Eapen GA; Casal RF; Sabath BF; Lin J; Cerrillos E; Nevarez Tinoco T; Grosu HB
J Bronchology Interv Pulmonol; 2024 Apr; 31(2):155-159. PubMed ID: 37982602
[TBL] [Abstract][Full Text] [Related]
5. Intrapleural fibrinolytic therapy (IPFT) in loculated pleural effusions--analysis of predictors for failure of therapy and bleeding: a cohort study.
Abu-Daff S; Maziak DE; Alshehab D; Threader J; Ivanovic J; Deslaurier V; Villeneuve PJ; Gilbert S; Sundaresan S; Shamji F; Lougheed C; Seely JM; Seely AJ
BMJ Open; 2013; 3(2):. PubMed ID: 23377992
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of pleural empyema in English hospitals and the impact of influenza.
Arnold DT; Hamilton FW; Morris TT; Suri T; Morley A; Frost V; Vipond IB; Medford AR; Payne RA; Muir P; Maskell NA
Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33334937
[TBL] [Abstract][Full Text] [Related]
7. Empyema in children.
Kuru M; Altinok T
Turk Gogus Kalp Damar Cerrahisi Derg; 2024 Jan; 32(Suppl1):S29-S36. PubMed ID: 38584781
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator with prolonged dwell time effectively evacuates pleural effusions.
Townsend A; Raju H; Serpa KA; Pruett R; Razi SS; Tarrazzi FA; Tami CM; Block MI
BMC Pulm Med; 2022 Dec; 22(1):464. PubMed ID: 36471325
[TBL] [Abstract][Full Text] [Related]
9. Extended Dwell Time Improves Results of Fibrinolytic Therapy for Complex Pleural Effusions.
Patino SH; Tarrazzi F; Tami C; Bellini A; Block M
Cureus; 2020 Aug; 12(8):e9664. PubMed ID: 32923260
[TBL] [Abstract][Full Text] [Related]
10. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
Altmann ES; Crossingham I; Wilson S; Davies HR
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
[TBL] [Abstract][Full Text] [Related]
11. Surgical versus non-surgical management for pleural empyema.
Redden MD; Chin TY; van Driel ML
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010651. PubMed ID: 28304084
[TBL] [Abstract][Full Text] [Related]
12. Mesothelial cells in tissue repair and fibrosis.
Mutsaers SE; Birnie K; Lansley S; Herrick SE; Lim CB; Prêle CM
Front Pharmacol; 2015; 6():113. PubMed ID: 26106328
[TBL] [Abstract][Full Text] [Related]
13. New therapy of pleural empyema by deoxyribonuclease.
Kacprzak G; Majewski A; Kolodziej J; Rzechonek A; Gürlich R; Bobek V
Braz J Infect Dis; 2013; 17(1):90-3. PubMed ID: 23332886
[TBL] [Abstract][Full Text] [Related]
14. Intrapleural therapy in management of complicated parapneumonic effusions and empyema.
Ahmed AH; Yacoub TE
Clin Pharmacol; 2010; 2():213-21. PubMed ID: 22291507
[TBL] [Abstract][Full Text] [Related]
15. Empyema thoracis: new insights into an old disease.
Brims FJ; Lansley SM; Waterer GW; Lee YC
Eur Respir Rev; 2010 Sep; 19(117):220-8. PubMed ID: 20956197
[TBL] [Abstract][Full Text] [Related]
16. A study of empyema thoracis and role of intrapleural streptokinase in its management.
Banga A; Khilnani GC; Sharma SK; Dey AB; Wig N; Banga N
BMC Infect Dis; 2004 Jun; 4():19. PubMed ID: 15222893
[TBL] [Abstract][Full Text] [Related]
17. BTS guidelines for the management of pleural infection.
Davies CW; Gleeson FV; Davies RJ;
Thorax; 2003 May; 58 Suppl 2(Suppl 2):ii18-28. PubMed ID: 12728147
[No Abstract] [Full Text] [Related]
18. Randomised trial of intrapleural urokinase in the treatment of childhood empyema.
Thomson AH; Hull J; Kumar MR; Wallis C; Balfour Lynn IM
Thorax; 2002 Apr; 57(4):343-7. PubMed ID: 11923554
[TBL] [Abstract][Full Text] [Related]
19. The pleural cavity.
Peek GJ; Morcos S; Cooper G
BMJ; 2000 May; 320(7245):1318-21. PubMed ID: 10807628
[No Abstract] [Full Text] [Related]
20. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas.
Sahn SA
Thorax; 1998 Aug; 53 Suppl 2(Suppl 2):S65-72. PubMed ID: 10193351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
